Skip common site navigation and headers
United States Environmental Protection Agency
Endocrine Disruptor Research Initiative
Contact Us | Print Version Search: NCER Advanced Search
Begin Hierarchical Links EPA Home > Table2.NCI >  00184-02 Prediagnostic Breast Cancer Serum Bank End Hierarchical Links End Hierarchical Links

 

EDRI Federal Project Inventory:
00184-02 Prediagnostic Breast Cancer Serum Bank



  1. Sponsor Organization: NIH/CN

  2. Project Title: 00184-02 PREDIAGNOSTIC BREAST CANCER SERUM BANK

  3. Project Focus: HUMAN HEALTH EFFECTS

  4. Description: A major obstacle to our understanding of the etiology of breast cancer is the lack of studies with prediagnostic serumfor analysis. This year, the Cancer Prevention Studies Branch assumed responsibility for the Columbia, Missouricollection of the Breast Cancer Serum Bank from the Division of Cancer Biology, Diagnosis, and Centers, NCI. Thiscollection includes serum collected between 1977 and 1987 from 7,641 women, 112 of whom subsequently developedbreast cancer. Questionnaires on reproductive history, use of exogenous estrogens and other medications, and cancerdiagnoses and treatment were completed at each blood drawing. We currently are evaluating estrogen and androgenlevels in serum from 74 women who developed postmenopausal breast cancer and 148 matched controls. A study toevaluate pesticide and PCB levels in serum from cases and noncases is being developed and a study to analyzeantioxidants is planned. Analyses of serum from the Breast Cancer Serum Bank will improve our understanding of therole of diet and hormones, as well as environmental exposures, in the etiology of breast cancer.

  5. References:

  6. Category: MEASUREMENTS

  7. Subcategory: BASIC RESEARCH

  8. Keywords for Experimental System/Species: HUMAN

  9. Keywords for Experimental Endpoints: HORMONE RECEPTORS, EXPOSURE MONITORING, CARCINOGENESIS

  10. Chemical Agents: NCI INTRAMURAL PROGRAM

  11. Performing Institution: PERFORMING INSTITUTION:

  12. Contact: ELAINE C. LEE; BUILDING 31; 11A21, NATIONAL CANCER INSTITUTE, NIH,BETHESDA, MD 20892-2590; 301- 496-5515; LEEE@OD.NCI.NIH.GOV


 

 
Begin Site Footer